Ichim et al. published preclinical data on a senescent cell immunization approach that primes the immune system to target senescent cells within solid tumors. The Journal of Translational Medicine paper presents evidence that vaccination against senescent cell antigens enhanced immune‑mediated tumor clearance in animal models. Authors position senescent cell immunotherapy as a complementary strategy to conventional cancer immunotherapies.